Cancer Drugs Fund ‘is papering over the cracks,’ say campaigners
England’s Cancer Drugs Fund is merely papering over the cracks of a system which is no longer fit for purpose, the government has been told.
Read MoreAuthor: Lynne Taylor
Health screenings: MPs slam poor communication
The risks and benefit of participating in health screening programmes are not being communicated consistently by either the NHS or private healthcare providers, says a committee of MPs.
Read MoreSaatchi Medical Innovation Bill must include off-label drug use, says peer
Conservative peer Lord Maurice Saatchi’s Medical Innovation Bill must include allowing physicians treating long-term chronic conditions to prescribe off-label drug treatments which they believe to be in the best interests of their patients, the House of Lords has been told.
Read MoreMedicines not goods like any other, says new EU president
Pharmaceutical policy in the new European Commission will be developed jointly by two Commissioners – one for the single market, industry and enterprises, and the other for health, Commission President-elert Jean-Claude Juncker has announced.
Read MoreNICE fast-tracks final ‘yes’ for GSK skin cancer drug
The National Institute for Health and Care Excellence has issued final guidance recommending GlaxoSmithKline’s Tafinlar (dabrafenib) for the treatment of melanoma which has spread or cannot be completely removed by surgery, and which tests positive for the BRAF V600 mutation.
Read More- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
